Notice of Annual General Meeting
September 29, 2022
Notice is hereby given that the 110th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
Notice is hereby given that the 110th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
PDL continues to see notifications involving forged prescriptions and would like to remind pharmacists of the need to be vigilant when assessing the validity of
PDL has recently received several incident reports where the incorrect varicella vaccine has been prescribed and/or supplied. Prescribing software programs have variations on how the
It is no surprise that the top four drugs on our list are Schedule 8’s (S8s). Dispensing errors can happen with any drug but the
The following vacancies will occur as of the date of the next Annual General Meeting to be held on 20 October 2022 One Director
Schedule 8 medicines, in particular opioids, are often involved in notifications to PDL. An Australian Institute of Health and Welfare report on opioid harm in
Lapsed Professional Indemnity insurance arrangements – Section 130(3)(a)(iii), National Law In busy working life, the renewal of professional indemnity insurance can easily be missed. Common
PDL Professional Officers have observed an increase in formal requests for information regarding dispensed medicines from the Real Time Prescription Monitoring (RTPM) sections of health
PDL representatives Gilbert Yeates (Qld Director) and Gary West (Professional Officer and Qld Local Advisory Committee Chair) were pleased to attend ConPharm 2022 at Sea
The recent surge in demand for influenza vaccines has also seen a rise in the number of vaccine-related calls and incident reports to PDL. This